CorMedix Inc. (CRMD)

Pharmaceutical Preparations

Latest Price

$7.70

TTM P/E

3.53

Normalized P/E

60.96

Div Yield

Book Value

5.87

P/B Ratio

1.31

Valuation metrics

EPS: $2.04

Book value / share: $5.11

Formula: √(22.5 × EPS × BVPS)

Graham Number

$15.32

+99% upside

EPS: $2.04

Target P/E: 61×

Formula: EPS × P/E

P/E Fair Value

$124.44

+1516% upside

57.3% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	6.32M	$49.0M	8.14%	+356.5K	2026-06-30
Deep Track Capital, LP	6.27M	$49.0M	8.08%	--	2026-06-30
Vanguard Capital Management LLC	3.14M	$24.0M	4.04%	+5.4K	2026-06-30
State Street Corp	2.32M	$18.0M	2.98%	+125.0K	2026-06-30
Royce & Associates LP	2.18M	$17.0M	2.80%	+288.8K	2026-06-30
Geode Capital Management, LLC	1.95M	$15.0M	2.51%	+130.1K	2026-06-30
UBS Group AG	1.88M	$14.0M	2.42%	+339.7K	2026-06-30
Oberweis Asset Management Inc/	1.32M	$10.0M	1.70%	+112.8K	2026-06-30
Alyeska Investment Group, L.P.	850.0K	$6.0M	1.09%	--	2026-06-30
Marshall Wace, LLP	779.5K	$6.0M	1.00%	+276.6K	2026-06-30